cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-064 ABT 414

ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Promotor Name : ABBVIE

Investigator Name : D. HARGRAVE

Trial registered on clinicaltrial.gov: NCT02343406